Aduro Biotech Enters into Exclusive License Agreement for Proprietary Neoantigen Identification Technology
Thermo Fisher Scientific Submits Premarket Approval Application to FDA for Next-Generation Sequencing-Based Oncology Test
Aduro Biotech Announces Key Preclinical Data Published Highlighting New Approach to Treat Multiple Myeloma
Summit Royalties Secures Up to US$50 Million Revolving Credit Facility; Provides Other Corporate Updates
NextSource Materials Announces Updated Feasibility Study Results for Molo Mine Expansion to 150k tpa of SuperFlake Graphite Concentrate
